Do you want to read an article? Please log in or register.
A new validated staging system for AL amyloidosis with Stage IIIC defining ultra-poor risk: AL International Staging System (AL-ISS)
Amyloidosis
Indications
Related content
Central Nervous System Tumors
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group
Lancet Oncol
Karschnia P, Young JS, Wijnenga MMJ, Sciortino T, Teske N, Corell A, Wagner A, Youssef G, Park YW, Häni L, Jünger ST, Dono A, Ehret F, Mireles EEM, Neidert N, Bruno F, Tuchek CA, van der Vaart T, Rossi M, Nibali MC, Gay L, Gramelt A, Tandon N, Ahn SS, Chang JH, Weller M, Vincent AJPE, Goldbrunner R, Cahill DP, Huang RY, Raabe A, Meyer B, Beck J, Molinaro AM, Chang SM, Vogelbaum MA, Rudà R, Vik-Mo EO, Dietrich J, Esquenazi Y, Grau SJ, Wen PY, Jakola AS, Schnell O, Bello L, van den Bent MJ, Hervey-Jumper S, Berger MS, Tonn JC
doi: 10.1016/S1470-2045(25)00534-0
Multiple Myeloma (MM)
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma
J Clin Oncol
Avet-Loiseau H, Davies FE, Samur MK, Corre J, D'Agostino M, Kaiser MF, Raab MS, Weinhold N, Gutierrez NC, Paiva SB, Neri P, Weisel K, Maura F, Walker BA, Bustoros M, Stewart AK, Usmani SZ, Hillengass J, Chng WJ, Keats JJ, Martinez-Lopez J, Sperling AS, Touzeau C, Zhan F, Raje NS, Cavo M, Bolli N, Ghobrial IM, Dhodapkar MV, Jagannath S, Spencer A, Parekh S, Bahlis NJ, Lonial S, Sonneveld P, Bergsagel L, Orlowski RZ, Morgan G, Mateos MV, Rajkumar SV, San Miguel JF, Anderson KC, Moreau P, Kumar S, Prósper F, Munshi NC
doi: 10.1200/JCO-24-01893
Lung, Respiratory and Thoracic Cancer
The International Association for the Study of Lung Cancer Staging Project: The Impact of Common Molecular Alterations on Overall Survival in NSCLC in Initial Analyses of the IASLC Ninth Edition Staging Database
J Thorac Oncol
Carbone DP, Hirsch FR, Osarogiagbon RU, Nishimura KK, Tsao MS, Travis WD, Yang D, Yang SR, Yatabe Y, Araujo LH, Detterbeck F, Lechtenberg KJ, Lim E, Mack PC, Matilla JM, Montuenga LM, Nicholson AG, Suda K, Terra RM, Rami-Porta R, Asamura H, Rusch V, Members of the IASLC Staging and Prognostic Factors Committee and of the Advisory Boards, and Participating Institutions
doi: 10.1016/j.jtho.2025.06.025
Lung, Respiratory and Thoracic Cancer
The International Association for the Study of Lung Cancer Staging Project: The Impact of Smoking Status on Lung Cancer Staging in the Ninth Edition of the TNM Classification
J Thorac Oncol
Eng L, Evans WK, Eisele M, Nishimura KK, Land SR, Rami-Porta R, Dresler CM, Asamura H, Fathi JT, Lechtenberg K, Rusch V, Sheikh M, Wynes MW, Zius K, Osarogiagbon RU, Warren GW, Members of the IASLC Staging and Prognostic Factors Group and of the Advisory Boards, and Participating Institutions and the IASLC Tobacco Control and Smoking Cessation Committee
doi: 10.1016/j.jtho.2025.07.002
Lung, Respiratory and Thoracic Cancer
Polygenic risk score to define risk of cancer-associated thrombosis among patients with lung cancer in a population-based study
Lung Cancer
Tafur A, Sebai A, Shi Z, Wei J, Tran H, Zheng SL, Krantz S, Hensing T, Mansfield AS, Xu J
doi: 10.1016/j.lungcan.2025.108712
Lymphoma
A New Prognostic Index (CLIPI) for Advanced Cutaneous Lymphoma Enables Precise Patient Risk Stratification
Blood
Scarisbrick JJ, Quaglino P, Whittaker SJ, Bagot M, Guenova E, Papadavid E, Prince HM, Sanches JA, Miyashiro D, Servitje O, Querfeld C, Akilov OE, Arumainathan A, Bennett L, Battistella M, Benstead K Dr, Berti EF, Beylot-Barry M, Busschots AM, Cowan RA, Dummer R, Dunnill G, Estrach MT, Evison F, Bashir AE, Geskin LJ, Gru A, Guitart J, Herrera MC, Hodak E, Horwitz SM, Jonak C, Klemke CD, Knobler R, McKay P, Marschalkó M, Massone C, Matin R, Mitteldorf C, Novoa RA, Ortiz-Romero PL, Pimpinelli N, Pujol RM, Ranki A, Vankeva L, Rieger KE, Stadler R, Trautinger F, Latzka J, Vermeer MH, Wachsmuth R, Weatherhead S, Wehkamp U, Wobser M, Kim YH
doi: 10.1182/blood.2025029628
Lymphoma
Secondary central nervous system lymphoma (SCNSL) in mantle cell lymphoma (MCL): Characteristics and risk factors in a Danish nationwide population-based study
Br J Haematol
Trab T, Ranadóttir T, Chanchiri I, Ludvigsen Al-Mashhadi A, Berggreen Dall E, Rasch S, Johansen M, Haunstrup LM, Cunsolo G, Poulsen CB, Larsen TS, Husby S, Brown P, Hawkes EA, El-Galaly TC, Grønbæk K
doi: 10.1111/bjh.70082
Multiple Myeloma (MM)
High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing
Blood
Schavgoulidze A, Perrot A, Leleu X, Cazaubiel T, Chretien ML, Feugier P, Belhadj K, Manier S, Roussel M, Brechignac S, Orsini Piocelle F, Mohty M, Schiano de Colella JM, Macro M Dr, Adiko D, Dib M, Fontan J, Motard C, Bouscary D, Pascal L, Roland V, Lifermann F, Bakala JA, Montes L, Kennel C, Rey P, Richez V, Keddar F, Frenzel L, Calmettes C, Chaleteix C, Plantier I, Chalayer E, Schmitt A, Roul C, Demarquette H, Cerutti C, Pavageau L, Derrier L, Avet-Loiseau H, Corre J
doi: 10.1182/blood.2025029999
Breast Cancer
Tailoring Treatment to Cancer Risk and Patient Preference: The 2025 St Gallen International Breast Cancer Consensus Statement on Individualizing Therapy for Patients With Early Breast Cancer
Ann Oncol
Burstein HJ, Curigliano G, Gnant M, Loibl S, Regan MM, Loi S, Denkert C, Poortmans P, Cameron D, Thurlimann B, Weber WP, Panelists of the St. Gallen International Breast Cancer Consensus 2025
doi: 10.1016/j.annonc.2025.09.007